Stockreport

After earnings plunge, BioNTech pins hopes on cancer drug launches [Reuters]

BioNTech SE - American Depositary Shares  (BNTX) 
PDF tab was widely used during the pandemic, reported on Wednesday a plunge in 2023 revenue and earnings as its focus shifts towards cancer drug development. The Mainz-bas [Read more]